Chassis
Case Pattern: Deploying a Reseller-Branded Medical Imaging AI into Hospitals
A composite walkthrough of how an imaging AI vendor turns a cloud-only diagnostic product into a sealed, hospital-deployable unit sold under a reseller partner's own name.
· 8 min read
The pattern below is a composite drawn from the shape recurring imaging-AI deals take, not a single named engagement. The specifics are illustrative, not a case study of an identified customer. It's useful because the shape recurs: an imaging AI company builds a strong triage or detection model, sells it as a cloud service to health systems that can tolerate cloud radiology workflows, and then runs into a reseller relationship that changes the deployment requirement entirely.
The setup: a cloud product, a reseller with hospital relationships
Call the vendor an imaging AI company with a model that flags likely findings on CT or X-ray studies (intracranial hemorrhage, pulmonary nodules, whatever the clinical focus happens to be) fast enough to matter in a radiologist's worklist triage. The product today is a cloud service: studies flow up from a PACS integration, inference happens on the vendor's infrastructure, results flow back as a priority flag or an overlay.
That product works well for health systems willing to route imaging studies through a cloud API. It does not work for the reseller partner now trying to sell it, because the reseller's own customer base skews toward hospital networks and imaging centers with policies, sometimes self-imposed, sometimes tied to state health information law, sometimes tied to a specific payer or government affiliation, that will not permit patient imaging to leave the facility's own network for inference. The reseller has the relationships and the sales motion. What it does not have is a way to sell a cloud-only product into that segment of its own pipeline, and the imaging AI company does not have a hardware practice.
This is the condition Chassis is built for: an ISV with working cloud software, a partner who needs to sell that software into a buyer segment the cloud architecture can't reach, and a specific deal (one hospital network, one modality, one set of facility constraints) rather than an abstract request to "make it on-prem."
What the reseller actually needs from the box
It is worth being precise about what the reseller is asking for, because it is narrower than a general on-premise version of the product. The reseller needs a physical unit that carries the reseller's own name rather than the imaging AI vendor's, because the hospital relationship belongs to the reseller, and the vendor may be a name the hospital's procurement and security teams have never evaluated. It needs to run the vendor's actual inference stack, the same model and triage logic the cloud product runs, inside the hospital's network boundary, with no outbound path for patient imaging to leave the facility looking for compute. It needs to integrate with that specific hospital's PACS and imaging workflow rather than a generic DICOM ingestion path, since imaging infrastructure varies enough facility to facility that "generic" integration usually means integration someone still has to finish on site. And it needs to ship as something the hospital's biomedical engineering and IT security teams can characterize once, a sealed appliance with a defined hardware boundary and a provenance record, rather than a server their own staff has to build, patch, and defend the configuration of indefinitely.
None of that is a request to rearchitect the imaging AI company's product. It is a request for a specific, sealed deployment target for a specific deal, which is a hardware and integration problem layered on top of software the vendor has already built and validated.
Why "just containerize it" undersells the problem
The instinct inside a cloud-native AI company facing this request is usually to reach for a deployment artifact: a container image, an installation script, a customer-managed VM. For most enterprise software that instinct is close enough. For a diagnostic imaging workload landing inside a hospital, it undersells several problems that only show up once the box has to survive contact with a real clinical environment and a real security review.
Clinical imaging workflows carry latency expectations tied to how radiologists actually triage a worklist, not to a lab benchmark. The hardware sizing underneath the model has to be scoped against real study volume and real turnaround expectations for that facility's caseload, not assumed from a generic reference deployment. Medical device and health-IT security review is also not the same review a general enterprise SaaS product goes through: a reviewer looking at a box that touches diagnostic imaging wants a defined hardware boundary, a tamper-evident enclosure, and a clear account of what leaves the network and what does not, a question a sealed, air-gapped-capable appliance answers structurally rather than through a policy document the hospital has to take on faith.
PACS and imaging network integration is genuinely per-site work, too. Modality vendors, PACS versions, and network segmentation differ enough hospital to hospital that a build has to be scoped against the actual environment it lands in, not a template that assumes every hospital's imaging network looks the same. Provenance matters more here than in most enterprise deployments, too: a hospital's biomedical and security teams want to know what went into the build, who signed it, and what changes since. That's a record that stands in for the vendor being physically present at every audit, which matters more for a system touching diagnostic output than for most back-office software.
An imaging AI company can absolutely solve all of this in house. Very few want to, because none of it is the discipline the company was built around, and building it well is a multi-quarter distraction from the model and clinical validation work that is actually the product's differentiation.
How the build takes shape
The pattern follows the same mechanics as any other Chassis engagement, scoped to this deal rather than pulled from a fixed configuration. The reseller and the imaging AI vendor bring the specifics: the hospital network, the modality and study volume the deployment needs to handle, the PACS environment it has to integrate with, the network posture (connected within the hospital's own segmented environment, or fully air-gapped, depending on that facility's requirements), and the reseller's own branding for the unit's exterior and any on-device interface.
Element 31 translates that into a hardware specification sized to the actual inference load, manufactures the enclosure, integrates the vendor's model and inference stack on top of Substrate, builds the PACS integration against that hospital's real environment, and seals the unit before it ships. What arrives at the hospital carries the reseller's name on the case and in whatever interface the radiology staff sees. The manufacturing and sealing discipline underneath is Element 31's, and it is not something the hospital's own review process needs to see or engage with directly. Their relationship is with the reseller, exactly as it was before imaging AI entered the conversation.
The imaging AI company's own codebase does not fork for this. The model, the inference logic, the clinical validation all stay the vendor's core product, running unmodified inside a deployment target built for this one engagement. What changes is packaging, hardware, network posture, and the identity the box presents to the hospital, not the software doing the diagnostic work.
What this pattern generalizes to
Nothing about this walkthrough is specific to imaging. The general shape underneath it is a cloud AI vendor with a real, validated product; a channel partner whose buyer relationship depends on that partner's own name being on the deployed unit; and an end customer (here a hospital, elsewhere a bank, a utility, a defense integrator) whose facility, data-residency, or security posture rules out the cloud path entirely. Regulated healthcare buyers are simply a clean illustration of the pattern, because the stakes of getting the network boundary wrong are legible to everyone in the room: a security officer, a compliance lead, and a radiologist all understand immediately why patient imaging should not leave the building looking for a GPU.
The commercial mechanics that make this work (how the reseller and the vendor split the economics of a hardware-bearing deal, what support and update responsibilities look like once the unit is inside a facility Element 31 does not operate) get worked out between the reseller and the imaging AI vendor as part of structuring the deal. That's a business-terms conversation between those two parties, not something a hardware and manufacturing partner sets on their behalf. What Element 31 is scoped to solve is the physical and software packaging problem underneath it: a sealed, provenance-tracked unit, built once per deal, that lets the reseller's hospital relationship and the vendor's cloud-validated model both survive contact with a network boundary the cloud product was never built to cross.